Literature DB >> 7537682

Regulation of substance P release mediated via prejunctional histamine H3 receptors.

T Ohkubo1, M Shibata, M Inoue, H Kaya, H Takahashi.   

Abstract

The involvement of the histamine H3 receptor in the regulation of substance P release in neurogenic inflammation was studied by using rat hindpaw skin. R-(-)-alpha-Methylhistamine, a specific histamine H3 receptor agonist, significantly inhibited the increased vascular permeability induced by antidromic electrical stimulation of the sciatic nerve in a dose-dependent manner at doses of 0.5-3 mg/kg (i.v.), and thioperamide (2 mg/kg i.p.), a specific histamine H3 receptor antagonist, prevented the inhibitory effect of R-(-)-alpha-methylhistamine. The antidromic stimulation also caused a significant increase in immunoreactive substance P release in the subcutaneous (s.c.) perfusate in the rat hindpaw. R-(-)-alpha-Methylhistamine (0.25-2 mg/kg) dose dependently inhibited the increase in release of immunoreactive substance P, and thioperamide (2 mg/mg i.p.) antagonized it. Perfusion of histamine (10(-3) M) elicited a significant increase of immunoreactive substance P release in the perfusate, which was reduced by R-(-)-alpha-methylhistamine and the antagonism of thioperamide was also observed. Histamine (in the presence of histamine H1 and H2 receptor antagonists) had an inhibitory effect on the electrically evoked release of immunoreactive substance P. These results strongly support the hypothesis that histamine regulates substance P release via prejunctional histamine H3 receptors that are located on peripheral endings of sensory nerves.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537682     DOI: 10.1016/0014-2999(94)00668-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells.

Authors:  N S Holden; W Gong; E M King; M Kaur; M A Giembycz; R Newton
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

2.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

Review 3.  H3 receptors and pain modulation: peripheral, spinal, and brain interactions.

Authors:  Lindsay B Hough; Frank L Rice
Journal:  J Pharmacol Exp Ther       Date:  2010-09-23       Impact factor: 4.030

4.  Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets.

Authors:  Keri E Cannon; Paul L Chazot; Victoria Hann; Fiona Shenton; Lindsay B Hough; Frank L Rice
Journal:  Pain       Date:  2006-11-28       Impact factor: 6.961

5.  Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively.

Authors:  Keri E Cannon; Rob Leurs; Lindsay B Hough
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

6.  Antihistaminic drugs modify casein-induced inflammation in the rat.

Authors:  P Rzodkiewicz; E Wojtecka-Lukasik; D Szukiewicz; W Schunack; S Maslinski
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

7.  Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin.

Authors:  P Holzer; M Jocic; B A Peskar
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor.

Authors:  Ying Shi; Rong Sheng; Tingting Zhong; Yu Xu; Xiaopan Chen; Dong Yang; Yi Sun; Fenyan Yang; Yongzhou Hu; Naiming Zhou
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 9.  Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease.

Authors:  Cecilia Flores-Clemente; María Inés Nicolás-Vázquez; Elvia Mera Jiménez; Maricarmen Hernández-Rodríguez
Journal:  Biomolecules       Date:  2021-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.